BUY Welspun Living Limited — Ashish Kyal, Waves Strategy Advisors
byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Welspun Global Brands Limited, a material subsidiary of Welspun Living Limited, has had its credit rating upgraded by India Ratings and Research Private Limited. The rating for bank loan facilities of
BSE · Company Update·16 Sept · 5d ago
India’s textile boom ahead? Why Jefferies is bullish on Welspun, Raymond
NewsEt-Markets·9 Sept · 2w ago
Why Is Jefferies Betting Big On India's Textile Opportunity? Initiates Welspun Living, Raymond Lifestyle With 'Buy'
NewsNdtv-Profit·9 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Welspun Living
- BUY — Kavita Jain, Arihant Capital Markets3 Nov 2026 · ~3 months · target ₹318 · SL hit
- BUY — Axis Securities2 Nov 2026 · ~2 weeks · target ₹260 · Target hit
- BUY — Somil Mehta, Sharekhan30 Oct 2026 · ~2 weeks · target ₹245 · Target hit
- BUY — Somil Mehta, Sharekhan23 Oct 2026 · ~2 weeks · target ₹225 · Target hit
- BUY — Siddharth Sedani, Anand Rathi22 Oct 2026 · ~1 year · target ₹235 · Target hit
More from Ashish Kyal, Waves Strategy Advisors
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,770 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,620 · Active
- BUY Jio Financial Services4 Nov 2026 · ~1 year · target ₹250 · Active
- BUY Engineers India4 Nov 2026 · Next day · target ₹320 · Expired
- BUY Dr. Lal Path Labs4 Nov 2026 · ~1 year · target ₹2,100 · Active

